REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Hameln Rds S. R. O. (Slovakia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hameln Rds S. R. O. Profile Updated: July 31, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Hameln RDS s.r.o. operates in pharmaceutical and healthcare manufacturing support. The company focuses on packaging, processing, and related services for medical products. Its activities emphasize compliance and quality control.

Headquarters
Horna, 36
Modra; Bratislavsky; Postal Code: 90001

Contact Details: Purchase the Hameln Rds S. R. O. report to view the information.

Basic Information
Total Employees:
Purchase the Hameln Rds S. R. O. report to view the information.
Registered Capital:
Purchase the Hameln Rds S. R. O. report to view the information.
Financial Auditors:
Purchase the Hameln Rds S. R. O. report to view the information.
Incorporation Date:
June 15, 1995
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Hameln Rds S. R. O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-6.52%▼
Total operating revenue
-3.87%▼
Operating Profit/Loss (EBIT)
-53.48%▼
EBITDA
-28.53%▼
Net Profit/Loss for the Period
-46.98%▼
Total Assets
-12.83%▼
Total Equity
3.81%▲
Operating Profit Margin (ROS)
-2.39%▼
Net Profit Margin
-1.45%▼
Return on Equity (ROE)
-3.52%▼
Debt/Equity
0%
Quick Ratio
1.25%▲
Cash Ratio
0.33%▲

Similar companies

Saneca Pharmaceuticals A. S.
 
Hbm Pharma S.R.O.
Unimed Pharma, Spol. S R.O.
 
Pharmagal - Bio, Spol. S R.O.
Imuna Pharm, A.S.
 
Biomin, A.S.
Panacea, S.R.O.
 
Galvex, Spol. S R.O.
Farmacia Martin A.S.
 
Pharmagal, Spol. S.R.O.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo